Episode Summary:
In this episode of Bettertech on Building Trust-Free Infrastructure for Genetic Data, host Colin McCarthy sits down with Ken Clark, CEO and founder of Enigma Genetics, to unpack who really controls your genetic data once you hand over that sample. A former combat infantryman turned engineer, Ken explains why companies are temporary but genomes are not, and what the 23andMe collapse exposed about consent, ownership, and risk. He walks through OmniMind, an AI health companion built as a biological memory, and the security thinking behind it. Ken also shares how consent-based clinical trial matching could give value back to patients, and why he believes doing the right thing consistently is the only real trust strategy.
Show Notes:
- Ken Clark shares his path from combat infantryman to engineer to founder of Enigma Genetics, and what led him to Build a Trust-Free Infrastructure for Genetic Data.
- The conversation covers how consent checkboxes and database ownership leave people with little control over their genetic data.
- Ken explains OmniMind, an AI that only knows one person and lives in a vault that only that person can access.
- Discussion dives into Enigma’s security design, including why the team moved away from zero knowledge encryption to user-held keys.
- Ken shares his view on where AI is heading, major platforms accepting health data uploads, and why doing the right thing long enough matters.
This episode is hosted by Colin McCarthy, Host, BetterTech